Suki was founded on the premise that the electronic health record, for all its benefits, turned physicians into data-entry clerks. Clinicians spend hours each day typing notes and clicking through interfaces, a burden widely cited as a leading driver of burnout. Suki's answer is a voice-first AI assistant that lets doctors talk naturally and have the technology do the work in the background — generating documentation, retrieving information, and handling administrative tasks without the physician ever touching a keyboard.
The company's flagship product, Suki Assistant, uses generative AI to ambiently listen to a patient-clinician conversation and automatically draft structured clinical notes. Beyond ambient documentation, Suki handles dictation, answers questions about a patient's history, assists with coding, and integrates the resulting notes directly into the EHR. The design philosophy is to make the technology recede into the background: invisible, assistive, and additive to the clinical encounter rather than a barrier within it.
Suki's commercial momentum reflected rising demand for ambient AI scribes. In October 2024 the company raised a $70M Series D led by Hedosophia, with a substantial investment from Venrock and participation from existing backers March Capital, Flare Capital, Breyer Capital, and inHealth Ventures. The round brought total funding to about $165M and was paired with an expanded partnership with MedStar Health. In January 2025 Suki added a strategic investment from Zoom Ventures, the investment arm of Zoom, reflecting interest in embedding clinical AI into telehealth and communication workflows.
Suki sells to individual physicians, group practices, and health systems where documentation burden directly erodes both clinician satisfaction and throughput. Its strategy is to be an interoperable assistant that works across EHRs and specialties rather than a closed system tied to one vendor, and to expand from documentation into a broader clinical operating layer. The ambient AI scribe market is crowded and competitive, but Suki's voice-first heritage, partnerships with large health systems, and platform ambitions position it as one of the established players in clinician-facing healthcare AI.